Filtered By:
Countries: Iran Health

This page shows you your search results in order of date. This is page number 15.

Order by Relevance | Date

Total 610 results found since Jan 2013.

Validation of the Persian Version of the Engagement in Meaningful Activities Survey (EMAS) in an Iranian Stroke Population: Predictors of Participation in Meaningful Activities
CONCLUSIONS AND RELEVANCE: The results indicate that the EMAS-P has acceptable reliability and validity among Iranian people with chronic stroke. Moreover, the EMAS-P showed good discriminant validity for age, depression, and disability level among them. What This Article Adds: The EMAS-P is a reliable and valid scale for assessing the engagement of Iranian chronic stroke survivors in meaningful activities and thus should be helpful in both clinical research and practice.PMID:35771732 | DOI:10.5014/ajot.2022.046623
Source: The American Journal of Occupational Therapy - June 30, 2022 Category: Occupational Health Authors: Moslem Cheraghifard Malahat Akbarfahimi Akram Azad Aaron M Eakman Ghorban Taghizadeh Source Type: research

Electrical stimulation of the brain may help people who stutter
When Guillermo Mejias was 7 years old, his parents sent him out to buy bread during a family holiday in southern Spain. Mejias still remembers his growing anxiety as he walked to the bakery, repeating what he would say over and over in his head. But when the moment arrived, he was unable to produce a single word. He recalls returning empty-handed, ashamed, and wondering what to tell his parents. “I was so tense that I had been inadvertently biting my cheeks and tongue and my mouth was bleeding,” he says. Mejias still stutters, but today, as a brain researcher at the Complutense University of Madrid, he investigate...
Source: Science of Aging Knowledge Environment - June 22, 2022 Category: Geriatrics Source Type: research

Effect of a low dose of empagliflozin on short-term outcomes in type 2 diabetics with acute coronary syndrome after percutaneous coronary intervention
CONCLUSION: The results of this study showed that adding low dose empagliflozin to standard care of ACS diabetic patients after PCI was associated with no significant reduction in negative cardiovascular outcomes during 6 months.PMID:35537720 | DOI:10.15537/smj.2022.43.5.20220018
Source: Saudi Medical Journal - May 10, 2022 Category: Middle East Health Authors: Seyed Mohammad H Adel Fateme Jorfi Hoda Mombeini Homeira Rashidi Saad Fazeli Source Type: research